The hereditary autosomal recessive disease ataxia telangiectasia (A-T) is caused by mutation in the DNA damage kinase ATM. ATM's main function is to orchestrate DNA repair, thereby maintaining genomic stability. ATM activity is increased in response to several stimuli, including ionising radiation (IR) and hypotonic stress. DNMT1-associated protein 1 (DMAP1) is a member of the TIP60-p400 histone acetyl transferase (HAT) complex, which acetylates histone H4 at lysine 16 (H4K16) to affect chromatin relaxation and modulate ATM activation. Here we demonstrate that DMAP1 is required for both modes of ATM activation. Knockdown of DMAP1 impaired IR-induced ATM activation and consequently resulted in radiosensitivity and impaired the G2/M checkpoint. Moreover, DMAP1 was also required for efficient ATM signalling in response to hypotonic stress. Overexpression of DMAP1 increased IRinduced ATM substrate phosphorylation, suggesting that DMAP1 function is rate limiting for ATM signalling. DMAP1 associated with TIP60-dependent HAT activity, and depletion of DMAP1 reduced H4K16 acetylation in response to DNA damage. Treatment with histone deacetylase inhibitors rescued IR-induced ATM signalling in Dmap1-depleted cells. These results suggest that DMAP1 is a critical regulator of ATM activity and function.
INTRODUCTION

ATM is inactivated in the genomic instability disorder ataxia telangiectasia (A-T). A-T is characterised by neurodegeneration,
cancer predisposition, premature ageing, immunodeficiency and genomic instability. 1, 2 Cells from A-T patients exhibit chromosomal instability, premature senescence and severe sensitivity to agents that induce DNA double-strand breaks (DSBs). 3, 4 ATM is a member of the phosphoinositide 3-kinase-related protein kinase family that includes A-T and Rad3-related (ATR) and the catalytic subunit of DNA-dependent protein kinase. 5, 6 DNA damage leads to the activation of ATM, which subsequently coordinates the cellular DNA damage response by phosphorylating numerous substrates. 7 ATM functions to ensure cell survival by halting the cell cycle while the damage is repaired. 8 Alternatively, in the presence of excessive damage, ATM signalling can trigger the activation of programmed cell death to maintain organismal integrity.
Following the induction of DSBs, ATM activation is likely to involve the sensing of changes in chromatin structure and consequent autoactivation of the kinase. 9 This is followed by the transition of ATM from an inactive dimer to an active monomeric form and concomitant autophosphorylation of several amino acid residues, including serine 1981 (or the orthologous serine 1987 in mice). Monomeric phosphorylated ATM is then bound by Nijmegen breakage syndrome protein 1 (NBS1), a component of the MRN complex (consisting of MRE11, Rad50 and NBS1). The MRN complex recruits ATM to DSBs, where ATM phosphorylates multiple proteins at serine or threonine residues followed by glutamine (the 'SQ/TQ' motif). [10] [11] [12] [13] Chromatin modifications have an important role in ATM signalling. Specifically, acetylation of histone H4 at lysine 16 (H4K16Ac) was shown to affect chromatin relaxation and modulate ATM activation and the DNA damage response. 14 The tumour suppressor TIP60 is a member of the MYST family of histone acetyltransferases. Along with its cofactor TTRAP (TRAF and TNF receptor associated protein), it is responsible for DNA damage-induced hyperacetylation of H4, which promotes the chromatin decondensation required for DNA repair.
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DNMT1-associated protein 1 (DMAP1) was initially identified as a protein associated with the N-terminal domain of DNMT1, and was shown to function as a transcriptional corepressor by interacting with histone deacetylase 2. 16 Later, DMAP1 was biochemically identified as a component of the TIP60-p400 histone acetyltransferase complex. 17, 18 However, the significance of DMAP1 for TIP60 function has not been further investigated.
Human DMAP1 and its yeast homolog Eaf2 contain a highly conserved SANT (SWI3-ADA2-NcoR-TFIIIB) domain, which mediates histone tail binding. 19, 20 It was previously shown that Dmap1 knockdown in mouse embryonic fibroblasts led to spontaneous DSBs. 21 However, the mechanistic basis for DMAP1 function in DNA repair remains largely unknown in mammals.
Here we demonstrate that DMAP1 is required for TIP60 function in the DNA damage response. Depletion of DMAP1 results in impaired ATM signalling, corroborating the notion that histone acetylation is a fundamental and crucial requirement for ATM function.
RESULTS
DMAP1 is required for ATM signalling and function in response to IR In order to understand the physiological role of DMAP1, we depleted DMAP1 using four independent siRNA (small interfering RNA) hairpins. DMAP1 mRNA levels were significantly reduced by each individual siRNA (Supplementary Figure 1a) and loss of DMAP1 did not adversely affect the cell cycle ( Supplementary  Figures 1b and c) . In response to IR, DMAP1 depletion led to a substantial decrease in phosphorylation of the ATM substrates, pS824-Kap1 and pS957-SMC1 (Figure 1a) . These results suggest that DMAP1 is required for ATM signalling induced by DSBs.
In order to study the role of DMAP1 in ATM signalling more closely, we investigated irradiation-induced foci (IRIF) of DNA damage signalling components. Knockdown of DMAP1 reduced IRIF of active ATM phosphorylated at serine 1981 (pATM) 5 min after IR treatment. Both the number of pATM foci/cell (Figures 1b  and c ) and the average intensity of these foci (Figures 1b  and d) were significantly reduced in DMAP1-depleted cells. A similar reduction was observed for irradiation-induced 53BP1 foci in DMAP1-depleted compared with siRNA control cells (Supplementary Figure 2) . At a later time point (45 min), no significant differences were observed, perhaps due to the actions of residual DMAP1 protein (Figures 1e and f, and Supplementary  Figure 2) . ATM function is required for cell cycle checkpoints, including the G2/M checkpoint in response to IR. 22 We monitored the tendency of cells to escape the G2/M checkpoint after IR treatment and enter mitosis, indicated by immunofluorescent detection of phosphorylated histone H3 by fluorescence-activated cell sorting. The experiment was performed with and without the mitotic inhibitor nocodazole, to arrest cells that had passed through the G2/M checkpoint in mitosis. A549 cells treated with DMAP1 siRNA arrested in mitosis to the same extent as control cells in the absence of IR treatment (Figures 2a and b) . Increasing doses of IR from 1 À 10 Gy decreased entry into mitosis, but this tendency was reduced in DMAP1 siRNA-treated cells. DMAP1 depletion consistently resulted in a higher percentage of cells escaping arrest (Figures 2a and b) , indicating that the ATMregulated G2/M checkpoint requires DMAP1 function. Representative flow cytometry plots for all IR doses are shown in Supplementary Figure 3 . To test the importance of DMAP1 in the radiation response further, we investigated clonogenic survival after IR. DMAP1 depletion reduced the numbers of colonies compared with controls to a similar extent as treatment with a pharmacological ATM inhibitor (Figure 2c ). It is worth noting that Figure 1 . DMAP1 is required for ATM signalling after IR. (a) HCT-116 cells were transfected with control siRNA or one of four different siRNAs against DMAP1. 48 h later cells were treated with 5 Gy IR, harvested after 1 h and whole cell lysates separated and immunostained for pATM, ATM, pSMC1, SMC1, pKAP1 and KAP1. (b) Cells were treated with a pool of DMAP1 siRNAs, and after 48 h treated with 2 Gy IR, fixed at the indicated time points and immunofluorescently stained for pATM. The mean number of foci/cell was quantified in (c, e). The pATM foci intensity was measured for at least 250 foci/experiment (d, f ). The P-value of three independent experiments was calculated using the Student's t-test (***Po0.001, **Po0.01, n.s. not significant).
DMAP1 depletion was performed by transient transfection, so DMAP1 protein levels are reduced at the time of IR treatment but presumably return to normal at later stages of the experiment (which last for 7 days). Thus the apparent difference in clonogenic survival is likely to be a direct reflection of DMAP1 function in the early cellular response to IR.
To investigate the role of DMAP1 in non-canonical ATM signalling, cultured cells were subjected to hypotonic stress. DMAP1 depletion also reduced ATM substrate phosphorylation in these conditions. S957-SMC1 phosphorylation and S824-Kap1 phosphorylation were reduced ( Figure 3a) . Conversely, overexpression of DMAP1 increased ATM substrate phosphorylation in response to both hypotonic shock and IR treatment. Basal ATM activity did not change (Figure 3b) . We also investigated the role of DMAP1 in response to stimuli that activate ATR signalling. DMAP1 depletion did not alter pS957-SMC1 and pS317-Chk1 phosphorylation in response to ultraviolet radiation (Figure 3c ). This is likely due to the minor role of ATM in pS957-SMC1 and pS317-Chk1 phosphorylation after ultraviolet radiation, as pharmacological ATM inhibition only led to a modest decrease in phosphorylation (Figure 3c) . Thus, DMAP1 function is dispensable for ATR signalling, but required for ATM pathway activation in response to both canonical and non-canonical ATM stimuli.
DMAP1 interacts with TIP60 and is required for histone H4 acetylation DMAP1 has been shown to be a stable subunit of the human NuA4 complex, 17, 18 but the relevance of DMAP1 function for TIP60 activity has not been analysed. Co-overexpression of HA-TIP60 with GFP-tagged DMAP1 followed by immunoprecipitation (IP) confirmed the biochemical interaction between the proteins (Figure 4a ), in agreement with the previous studies that used IP/mass spectrometry approaches.
We next investigated the role of DMAP1 in regulating TIP60 histone acetyltransferase (HAT) activity. Overexpressed tagged TIP60 was immunoprecipitated, washed IPs were incubated with a colourimetric histone substrate, and HAT activity determined by spectrophotometry. As expected, TIP60 IPs contained significant HAT activity (Figure 4b) . Similarly, DMAP1 IPs were also associated with HAT activity (Figure 4c ). To investigate the relative contribution of TIP60 to DMAP1-associated HAT activity, TIP60 mRNA was depleted by transfection of siRNAs (Supplementary Figure 4a) . Knockdown of TIP60 did not alter the cell cycle distribution significantly ( Supplementary Figures 4b and c) , but reduced DMAP-1-associated HAT activity (Figure 4d ). Thus TIP60 accounts for a significant proportion of the HAT activity connected with DMAP1.
H4K16 is mainly acetylated by the histone acetyltransferases MOF and TIP60, 13, 23, 24 and H4K16Ac has recently been shown to be required for efficient ATM signalling. 14 We thus tested the hypothesis that DMAP1 might control ATM signalling by affecting the levels of H4K16Ac. Irradiation resulted in an increase in H4K16Ac levels, which were reduced upon depletion of DMAP1 (Figure 5a ). Trichostatin A (TSA) is an organic compound that selectively inhibits the class I and II mammalian histone deacetylase families of enzymes, thereby increasing substrate acetylation levels. TSA treatment rescued the decrease in H4K16Ac levels in DMAP1-depleted conditions (Figures 5b and c) . Importantly, TSA treatment also ameliorated the defects in IR-induced Smc1, Kap1 and p53 phosphorylation caused by DMAP1 depletion (Figures 5b and d) . Depletion of TIP60 had a similar effect on IR-induced ATM substrate phosphorylation as DMAP1 depletion, consistent with the idea that they work together (Figure 5d ). TSA treatment also rescued impaired 53BP1 IRIF formation in DMAP1-depleted cells (Figures 5e and f) . Thus, DMAP1 appears to be required for ATM signalling in response to DSBs by regulating the extent of acetylation of histone H4 at lysine 16, via TIP60.
DISCUSSION
In this study, we identify a role of DMAP1 in ATM signalling. DMAP1 is important for histone acetylation, which in turn regulates chromatin structure and the ATM-dependent DNA damage response.
It has been known that ATM activation in response to DNA damage is associated with chromatin changes. 9, 25 Moreover, previously it was shown that H4K16 acetylation is an important histone modification for ATM signalling.
14 H4K16 acetylation is dramatically downregulated with the loss of DMAP1. Thus, it is Figure 2 . DMAP1-deficient cells are radiosensitive. A549 cells were transfected with DMAP1 or control siRNA, and after 48 h were irradiated at the doses indicated. Cells were immediately incubated in the presence of either (a) DMSO or (b) nocodazole and after 18 h fixed and analysed for phospho-serine 10 histone H3 (pH3) by FACS analysis. In (c) A549 cells were transfected with siDMAP1 or control siRNA. After 48 h, DMSO or ATM inhibitor (ATMi) was added, and 1 h later cells were treated with the indicated radiation doses and counted. 1000 cells were plated per condition, and the number of colonies formed was counted 7 days later. At least three independent experiments were performed and P values calculated using the Student's t-test (*Po0.05; **Po0.01).
likely that DMAP1 promotes ATM activation by affecting chromatin modifications, including H4K16Ac. However, we cannot rule out that DMAP1, and the TIP60 acetyltransferase, also affect ATM signalling by regulating the acetylation of nonhistone substrates. Most importantly, it has been shown that acetylation of ATM itself may regulate its activation. 26, 27 However, we have not been able to detect ATM acetylation reliably (data not shown).
It is an open question how DMAP1 regulates TIP60 activity. Although DMAP1 was found to be associated with the NuA4/TIP60 complex, its biochemical function within the complex is not known. The SANT domain of mammalian DMAP1, which is also present in the yeast homolog Eaf2, interacts with histone tails. 19, 20 It is therefore tempting to speculate that DMAP1 might impart some positional information on TIP60, to determine the induction and precise location of H4K16 acetylation.
Because the effect of depleting DMAP1 was strongest a few minutes after irradiation, it appears that IRIF formation is delayed but not abolished in DMAP1-depleted cells. Although H4K16Ac levels were reduced, some acetylation was retained (Figure 5a ), which could be sufficient for slower foci formation. This H4K16 acetylation could be from residual DMAP1 remaining after the knockdown, or from other histone acetyltransferases, such as MOF, partially compensating for the reduction in acetylation by the DMAP1 À TIP60 complex. A previous study showing no effect of DMAP1 depletion on ATM phosphorylation 6-8 h after irradiation 21 is consistent with our results at the later time point of 45 min, and with a delay in IRIF formation in DMAP1-depleted cells. Downregulation of H4K16 acetylation is a hallmark of human cancers. 28 Besides being considered as a biomarker of human cancers, loss of H4K16 acetylation could promote tumourigenesis by abrogation of the ATM-dependent DNA damage response. In line with this, mono-allelic loss of the human TIP60 gene occurs frequently in human lymphomas and head-and-neck and mammary carcinomas. Also in mice, TIP60 is a potent haploinsufficient tumour suppressor of Myc-induced lymphomagenesis. 29 These data indicate that TSA and other HDAC inhibitors that impact on H4K16 acetylation and ATM signalling may have therapeutic potential for cancer treatment.
MATERIALS AND METHODS
Cell culture and treatment
HCT-116, A549 and 293A cells were cultured in Dulbecco's modified eagle medium supplemented with 10% fetal calf serum. Transfections were performed with Lipofectamine-2000 (11668-019, Invitrogen, Paisley, UK) according to the manufacturer's protocol. In some cases cells were treated with 10 mM ATM inhibitor (118500, Calbiochem, Schwalbach am Taunus, Germany) or 5 mM TSA (T8552, Sigma, Poole, UK) during the course of the experiment. IR experiments were performed using a Cs137 Gamma Irradiator at 2.1 Gy/min. Hypotonic swelling was performed using 50 mM NaCl in 1% fetal bovine serum/phosphate-buffered saline supplemented with 0.45% glucose. Cells were harvested in Buffer A (150 mM NaCl, 80 mM Tris-HCl (pH 7.2), 0.2% NP-40, 10% Glycerol) supplemented with 1 mM Na 3 VO 4 , 1mM b-glycerophosphate, 50 mM NaF and complete protease inhibitor cocktail (Sigma). For cell cycle profiling, cells were stained with Hoechst and analysed using a FACScan (Becton Dickinson, Oxford, UK). 
Western blotting
Western blots were performed using standard procedures. Protein samples were separated by SDS-polyacrylamide gel electrophoresis, and subsequently transferred onto polyvinylidene difluoride membranes. The following antibodies were used: pS1981-ATM (4526, Cell Signaling Technology, Hitchin, UK); ATM (2C1, Santa Cruz Biotechnology, Heidelberg, Germany), pS824-Kap1 (Bethyl Laboratories, Montgomery, TX, USA); Kap1 (Bethyl Laboratories Montgomery, TX, USA); b-actin (A5060, Sigma); a-tubulin (7291, Abcam, Cambridge, UK); pS957-SMC1 (5D11G5, Millipore, Watford, UK); SMC1 (AB3908, Millipore); pS317-Chk1 (2344, Cell Signaling Technology); pS15-p53 (9284, Cell Signaling Technology); p53 (sc126, Santa Cruz Biotechnology) H4K16-Ac (05-1232 Millipore); Myc (C3956, Sigma), GFP (TA155041, Origene, Rockville, MD, USA) and HRP-conjugated goat antimouse/rabbit immunoglobulin G (Jackson, PA, USA). All primary antibodies were used at 1:1000 dilution and secondary antibodies at 1:5000.
Immunofluorescence
HCT-116 cells were adhered onto slides, treated as indicated and fixed with 4% paraformaldehyde. Cells were permeabilised with 0.5% Triton/ phosphate-buffered saline and blocked with 10% fetal calf serum/ phosphate-buffered saline/0.1% Triton X100 before addition of primary antibody diluted 1:400 in blocking buffer: pS1981-ATM (4526, Cell Signaling Technology) or 53BP1 (sc22760, Santa Cruz Biotechnology). Cells were washed three times with blocking buffer then incubated with secondary antibody (AlexaFluor 568 and AlexaFluor 488; Invitrogen) diluted 1:400 in blocking buffer for 1 h. Cells were washed with phosphate-buffered saline and stained with 4',6-diamidino-2-phenylindole before mounting in Mowiol (475904, Calbiochem). Cells were imaged using a LSM 510 confocal microscope (Zeiss, Cambridge, UK). For quantification of IF images, a minimum of 100 cells for each experimental condition were counted. Washed immunoprecipitates were incubated with a colourimetric histone substrate, and HAT activity determined by spectrophotometry. Machine background was subtracted, and experimental values were normalised to a reaction containing no immunoprecipitate. The P-value of three independent experiments was calculated using the Student's t-test (*Po0.05).
Real-time PCR mRNA was isolated from cells using a Qiagen RNeasy Micro Kit (Qiagen, Manchester, UK) and cDNA was synthesised according to the manufacturer's protocol (Roche, 11483188001). Real-time PCR was performed using the following primers:
Radiosensitivity assays
For G2/M checkpoint analysis, 10 mM ATM inhibitor (Calbiochem, 118500) or DMSO was added to transfected cells 1 h before irradiation. After irradiation at the indicated dosages, cells were treated with 40 nM nocodazole (M1404, Sigma) or DMSO, for 18 h. Cells were fixed in 70% ethanol, stained with pSer10-H3 antibody (06-570, Cell Signaling Technology) followed by incubation with Alexa647 secondary antibody (A-31571, Invitrogen). Fluorescence-activated cell sorting was performed using an LSR II Flow Cytometer (BD, Oxford, UK). Analysis was carried out using FlowJo (Tree Star, Ashland, OR, USA) software. For postirradiation survival analysis, transfected cells were irradiated at the indicated doses. Cells were immediately trypsinised, counted using a Vi-Cell XR cell counter (Beckman Coulter, High Wycombe, UK) and 1000 cells plated out per condition in 60 mm dishes. Seven days later crystal violet was used to count the number of colonies formed.
Co-IPs
For coIPs, 293A cells coexpressing GFP-DMAP1 and HA-TIP60 were lysed in buffer A, sonicated and cleared by centrifugation for 10 min at 4 1C. Lysates were immunoprecipitated overnight with either antibodies against GFP Representative images are shown in (e) and a quantification in (f ); P-values were calculated using the Student's t-test (*Po0.05).
(Origene TA150041), HA (H6908, Sigma) or Immunoglobulin G control (02-6102, Invitrogen). Immunocomplexes were captured using Protein A and Protein G beads (Sigma), washed four times with buffer A and resuspended in Laemmli sample buffer.
HAT assays
For HAT assays, cell lysates were immunoprecipitated as described, using either HA (H6908, Sigma) or Myc (C3956, Sigma) antibodies. Immunocomplexes were resuspended in Buffer A, and HAT activity was measured with a colourimetric Histone Acetyltransferase Activity Assay Kit (65352, AbCam, UK) according to the manufacturer's protocol.
